EE200200540A - N-(heterotsüklüül)benseen- või -püridiinsulfoonamiidid kui tromboosi- ja hüübimisvastased ained - Google Patents

N-(heterotsüklüül)benseen- või -püridiinsulfoonamiidid kui tromboosi- ja hüübimisvastased ained

Info

Publication number
EE200200540A
EE200200540A EEP200200540A EEP200200540A EE200200540A EE 200200540 A EE200200540 A EE 200200540A EE P200200540 A EEP200200540 A EE P200200540A EE P200200540 A EEP200200540 A EE P200200540A EE 200200540 A EE200200540 A EE 200200540A
Authority
EE
Estonia
Prior art keywords
sulphonamides
thrombotic
heterocyclyl
pyridine
benzene
Prior art date
Application number
EEP200200540A
Other languages
English (en)
Inventor
Altenburger Jean-Michel
Cremer G�rard
Lassalle Gilbert
Matrougui Mostafa
Original Assignee
Sanofi-Synthlabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthlabo filed Critical Sanofi-Synthlabo
Publication of EE200200540A publication Critical patent/EE200200540A/et
Publication of EE05084B1 publication Critical patent/EE05084B1/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
EEP200200540A 2000-03-23 2001-03-22 N-(heterotskll)benseen- v?i -pridiinsulfoonamiidid kui tromboosi- ja hbimisvastased ained EE05084B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0003724A FR2806722B1 (fr) 2000-03-23 2000-03-23 Derives de n-(heterocyclylbutyl) benzene-ou pyridine sulfonamide, leur preparation et leur application en therapeutique
PCT/FR2001/000861 WO2001070736A1 (fr) 2000-03-23 2001-03-22 N-(heterocyclyl)benzene-ou pyridine sulfonamides comme agents antithrombotiques et anticoagulantes

Publications (2)

Publication Number Publication Date
EE200200540A true EE200200540A (et) 2004-04-15
EE05084B1 EE05084B1 (et) 2008-10-15

Family

ID=8848428

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200540A EE05084B1 (et) 2000-03-23 2001-03-22 N-(heterotskll)benseen- v?i -pridiinsulfoonamiidid kui tromboosi- ja hbimisvastased ained

Country Status (35)

Country Link
US (1) US6680329B2 (et)
EP (1) EP1268469B1 (et)
JP (1) JP2003528098A (et)
KR (1) KR100791693B1 (et)
CN (1) CN1183128C (et)
AR (1) AR029900A1 (et)
AT (1) ATE269325T1 (et)
AU (2) AU4661701A (et)
BG (1) BG65863B1 (et)
BR (1) BR0109385A (et)
CA (1) CA2401637C (et)
DE (1) DE60103868T2 (et)
DK (1) DK1268469T3 (et)
EA (1) EA004986B1 (et)
EE (1) EE05084B1 (et)
ES (1) ES2222358T3 (et)
FR (1) FR2806722B1 (et)
HK (1) HK1051537A1 (et)
HR (1) HRP20020762B1 (et)
HU (1) HUP0300695A2 (et)
IL (2) IL151619A0 (et)
IS (1) IS2304B (et)
ME (1) MEP17408A (et)
MX (1) MXPA02009276A (et)
NO (1) NO324835B1 (et)
PL (1) PL204660B1 (et)
PT (1) PT1268469E (et)
RS (1) RS50370B (et)
SI (1) SI1268469T1 (et)
SK (1) SK286687B6 (et)
TR (1) TR200402343T4 (et)
TW (1) TWI290141B (et)
UA (1) UA71667C2 (et)
WO (1) WO2001070736A1 (et)
ZA (1) ZA200206996B (et)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE443699T1 (de) * 2002-12-06 2009-10-15 Purdue Research Foundation Pyridine zur behandlung von verletztemsäugetiernervengewebe
US8729107B2 (en) * 2002-12-06 2014-05-20 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
WO2005102991A1 (ja) * 2004-04-19 2005-11-03 Daiso Co., Ltd. 非天然型アミノ酸の製造方法およびその中間体
US7750162B2 (en) 2004-04-19 2010-07-06 Daiso Co., Ltd. Process for preparation of nonnatural amino acid and intermediate thereof
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
US8586748B2 (en) * 2008-04-09 2013-11-19 Boehringer Ingelheim International Gmbh 2-sulfonylamino-4-heteroaryl butyramide antagonists of CCR10
CA2725140A1 (en) * 2008-05-22 2009-11-26 Boehringer Ingelheim International Gmbh Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
CA2788417C (en) * 2010-01-28 2017-02-14 The Medicines Company (Leipzig) Gmbh Trypsin-like serine protease inhibitors, and their preparation and use
FR2981071B1 (fr) * 2011-10-10 2014-02-07 Centre Nat Rech Scient Synthese versatile et stereospecifique d'acides amines gamma,delta-insatures par la reaction de wittig

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2727410B1 (fr) * 1994-11-25 1996-12-20 Synthelabo Chlorures de sulfonyles, leur preparation et leur utilisation comme intermediaires de synthese
FR2728570B1 (fr) * 1994-12-23 1997-04-11 Synthelabo Derives de 1-oxo-2-(phenylsulfonylamino)pentylpiperidine, leur preparation et leur application en therapeutique
FR2756285B1 (fr) * 1996-11-22 1998-12-18 Synthelabo Derives de n-(imidazolylbutyle)benzenesulfonamide, leur preparation et leur application en therapeutique
FR2756220B1 (fr) * 1996-11-27 1998-12-24 Lorraine Laminage Roue pour vehicule terrestre a moteur
FR2771094B1 (fr) * 1997-11-19 2000-02-04 Synthelabo Derives de piperidine-2-carboxylate, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
RS50370B (sr) 2009-11-10
HUP0300695A2 (hu) 2003-07-28
UA71667C2 (uk) 2004-12-15
MEP17408A (en) 2010-06-10
CA2401637A1 (en) 2001-09-27
US20030207920A1 (en) 2003-11-06
AR029900A1 (es) 2003-07-23
KR20020081476A (ko) 2002-10-26
US6680329B2 (en) 2004-01-20
IS2304B (is) 2007-10-15
ATE269325T1 (de) 2004-07-15
IS6535A (is) 2002-08-30
BR0109385A (pt) 2003-06-03
EA200200838A1 (ru) 2003-04-24
JP2003528098A (ja) 2003-09-24
DK1268469T3 (da) 2004-10-11
TR200402343T4 (tr) 2004-12-21
HK1051537A1 (en) 2003-08-08
FR2806722B1 (fr) 2002-05-17
CA2401637C (en) 2009-11-10
ZA200206996B (en) 2003-09-01
HRP20020762A2 (en) 2003-12-31
NO20024496L (no) 2002-11-22
EE05084B1 (et) 2008-10-15
BG107130A (bg) 2003-06-30
WO2001070736A1 (fr) 2001-09-27
HRP20020762B1 (en) 2005-02-28
PT1268469E (pt) 2004-10-29
TWI290141B (en) 2007-11-21
CN1183128C (zh) 2005-01-05
IL151619A0 (en) 2003-04-10
CN1426407A (zh) 2003-06-25
YU67002A (sh) 2005-07-19
IL151619A (en) 2009-05-04
EA004986B1 (ru) 2004-10-28
SK286687B6 (sk) 2009-03-05
EP1268469A1 (fr) 2003-01-02
PL204660B1 (pl) 2010-01-29
PL364988A1 (en) 2004-12-27
ES2222358T3 (es) 2005-02-01
MXPA02009276A (es) 2003-05-23
SK13512002A3 (sk) 2003-03-04
BG65863B1 (bg) 2010-03-31
DE60103868D1 (de) 2004-07-22
DE60103868T2 (de) 2005-06-09
NO20024496D0 (no) 2002-09-19
SI1268469T1 (en) 2004-10-31
NO324835B1 (no) 2007-12-17
EP1268469B1 (fr) 2004-06-16
AU2001246617B2 (en) 2006-03-02
FR2806722A1 (fr) 2001-09-28
KR100791693B1 (ko) 2008-01-03
AU4661701A (en) 2001-10-03

Similar Documents

Publication Publication Date Title
DK1282611T3 (da) Substituerede phenylacetatamider og anvendelse deraf som glucokinaseaktivatorer
DK1343542T3 (da) Bærer med fast fibrinogen og fast thrombin
NO20022334L (no) Ny sammensetning og anvendelse
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
NO20014135D0 (no) Nye sulfonamidforbindelser og deres anvendelse
DE60111534D1 (de) Alpha-acyl- und alpha-heteroatom-substituierte benzenacetamide verwendbar als glucokinase-aktivatoren
DE50112013D1 (de) Deodorantien und antiperspirantien
DE60216254D1 (de) Acrylkautschukzusammensetzung und vulkanisat
DE60214413D1 (de) Thiophen- und thiazolsulfonamide als antineoplastische mittel
EE200200540A (et) N-(heterotsüklüül)benseen- või -püridiinsulfoonamiidid kui tromboosi- ja hüübimisvastased ained
DE60208700D1 (de) Schälgerät und zugehörige verfahren
FI20001715A0 (fi) Rankoihin liittyvät järjestelyt ja menetelmät
DE50112472D1 (de) Abstreifer und Gutförderer
FR2833599B1 (fr) Polysaccharide amphotere, composition et utilisation
AU2001246617A1 (en) N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants
DK1274450T3 (da) Medicinsk anvendelse af agonister og antagonister af IL-174
NO20033425D0 (no) Surfaktant/oksidasjonsmiddellösning og fremgangsmåter for anvendelse av samme
FI112705B (fi) Saranat
NO20010858D0 (no) Fastpunktbeslag
DK1366039T3 (da) Piperazinylcarbonylquinoliner og -isoquinoliner
DK1317478T3 (da) Skelnen mellem GnRH-I og GnRH-II
DE50201491D1 (de) Stossverbindung von Arbeitsplatten
ATA7822002A (de) Holzwandtafel
DE60219418D1 (de) Silanylphenole und -naphthole
NO20015906L (no) Spleisosomprotein og dets anvendelse

Legal Events

Date Code Title Description
HC1A Change of owner name
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20120322